Cited by 625Aortic aneurysm repair treatmentsAortic Disease and Treatment ApproachesConnective tissue disorders research

Abdominal Aortic Aneurysm: Pathogenesis and Implications for Management

Golledge, Jonathan, Muller, Juanita, Daugherty, Alan, Norman, Paul·2006·Arteriosclerosis Thrombosis and Vascular Biology

Abstract

Abdominal aortic aneurysm (AAA) affects approximately 5% of elderly men and is responsible for a significant number of deaths in Western Countries. At present surgery by open or endovascular means is the only widely used therapy for this condition. In this review we examine the risk factors, serum, and genetic associations of AAA. Epidemiology studies suggest that smoking cessation and control of cholesterol and blood pressure should reduce the number of patients developing AAA. Natural history studies suggest that smoking cessation should reduce the rate of progression of AAA. Clear level 1 evidence for drug treatments of AAA are presently lacking; however, animal and human in vitro studies suggest that medication targeted at reducing inflammation and proteolysis are most likely to be beneficial, with limited data to support the use of statins, Angiotensin II inhibitors, and macrolides. Work has commenced in understanding which patients, identified by clinical, serum, and genotype, are more at risk of AAA progression and thus should be selected out for aggressive treatment. Well designed large multicenter randomized controlled trials are required to examine the medical treatment of AAA.

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000245819.32762.cb

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Abdominal aortic aneurysm is a risk-equivalent condition and is associated with age, male sex, personal history of atherosclerotic cardiovascular disease, smoking, hypertension and dyslipidaemia, while diabetic patients are at decreased risk.

    “The presence of an abdominal aortic aneurysm represents a riskequivalent condition and is associated with age, male gender, personal history of atherosclerotic CVD, smoking, hypertension and dyslipidaemia, 415 while, in contrast, diabetic patients are at decreased risk.”

    From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [415]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Golledge, J., Muller, J., Daugherty, A., & Norman, P.
Affiliations
University of Kentucky (US)
Venue
Arteriosclerosis Thrombosis and Vascular Biology
Published
2006-12
Volume
26
Issue
12
Pages
2605-2613
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2164258641
Cited by
625
References
116
Citations by year
2026: 23 · 2025: 22 · 2024: 31 · 2023: 31 · 2022: 42 · 2021: 37 · 2020: 27 · 2019: 34 · 2018: 35 · 2017: 35 · 2016: 40 · 2015: 32 · 2014: 35 · 2013: 37 · 2012: 34
FWCI
3.49
Type
journal article
Language
en
Open access
closed
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • ResearchOnline at James Cook University (James Cook University) (submittedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Funders
  • National Institutes of Health (5r01hl080010-05)
  • National Heart, Lung, and Blood Institute (R01 HL 080010-01)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic aneurysm repair treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
Keywords
abdominal aortic aneurysm, risk factors, genetic association, serum biomarkers, smoking cessation, cholesterol management, blood pressure control, aneurysm progression, natural history (disease), endovascular repair, open surgical repair, statins, macrolides, anti-inflammatory therapy, proteolysis, pharmacotherapy
MeSH terms
Animals, Humans, Inflammation, Risk Factors, Smoking Cessation, Aortic Aneurysm, Abdominal, Macrolides, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review